Document is current
Any future updates will be listed below
-
Authors
Cabrero Segurado, MA.
Bastida, JM.
Gilabert, C.
Sánchez Barba, M
Díaz-Ajenjo, L.
Gonzalez-Galan, AM.
Lama-Villanueva, A.
García-Jaen, P.
de la Cruz Corral, MG.
Hernandez Hernandez, ML.
Perez-Garcia, M.
Gutierrez-Sampedro, NS.
Junco-Dopico, C.
Alvaro-Sanchez, S.
Vazquez Iglesias, L.
Benito, R.
Hernandez-Rivas, JM.
Doyague Sanchez, MJ.
Costas Rodriguez, T.
González-Porras, JR.
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI24/01458)
Instituto de Salud Carlos III (PI24/01458)
Instituto de Salud Carlos III (PI24/01458)
Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH 2020)
Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH 2020)
Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH 2020)
Insituto de Salud Carlos III (PI24/01987)
Insituto de Salud Carlos III (PI24/01987)
Insituto de Salud Carlos III (PI24/01987)
Insituto de Salud Carlos III (PI24/01987)
Insituto de Salud Carlos III (PI24/01987)
Insituto de Salud Carlos III (PI24/01987)
Gerencia Regional de Salud de Castilla y León (GRS2147/A/2020)
- License Information
-
More Information
Article History
Received: 12 September 2025
Accepted: 21 January 2026
First Online: 29 January 2026
Declarations
:
: This was a prospective and longitudinal study to investigate the HRQoL in women with non-structural HMB This study was conducted in accordance with the principles of the Declaration of Helsinki and its subsequent amendments. Ethical approval was obtained from the Institutional Review Board (IRB) of the Complejo Asistencial Universitario de Salamanca (Approval Number: PI 2023-04-1280) and written informed consent was obtained from all participants.
: Not applicable.
: The authors declare no competing interests.
